AI-Guided SERS Defines a Pan-Cancer Diagnostic Biomarker.
This study presents an AI-powered SERS (Surface-Enhanced Raman Scattering) chip that enables early and accurate detectio...
The Silent Threat to Clinical Excellence: Ageism in Medicine.
- Post category:Supportive Oncology
- Reading time:1 min read
This publication addresses the pervasive issue of ageism in healthcare, illustrating its impact through the case of a 72...
Misinformation: The Unmeasured Biomarker Shaping Outcomes
- Post category:Patient Communication/Supportive Oncology
- Reading time:3 mins read
The most precise cancer therapy means nothing if the patient declines it.That’s not a failure of medicine - it’s a failure of transmission. Patients now arrive with TikToks, chatbot printouts,…
Real-world data and clinical experience from over 100,000 multi-cancer early detection tests.
- Post category:Supportive Oncology
- Reading time:1 min read
This study evaluated the real-world performance of the Galleri® multi-cancer early detection (MCED) blood test in over...
Brain metabolic vulnerability in 18-F FDG PET/CT predict future depression risk in young cancer survivors.
- Post category:Supportive Oncology
- Reading time:1 min read
This multicenter longitudinal study investigated the use of 18-F FDG PET/CT imaging to identify brain metabolic markers...
Five Proven Systems Reducing Financial Toxicity at Diagnosis.
- Post category:Supportive Oncology
- Reading time:4 mins read
Financial toxicity isn’t a side effect of cancer treatment. It’s a predictable outcome of a care model that was never built to handle the cost of staying alive. We engineered…